Literature DB >> 19484449

A case of iris melanocytoma transformed to malignant melanoma.

Ryo Inoue, Yoshitsugu Saishin, Chiharu Shima, Hiroshi Yoshikawa, Nobuyuki Ohguro, Yasuo Tano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19484449     DOI: 10.1007/s10384-008-0649-0

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  5 in total

1.  Malignant transformation of iris melanocytoma to iris ring melanoma.

Authors:  Mandeep S Sagoo; Prithvi Mruthyunjaya; Ian Cree; Philip J Luthert; John L Hungerford
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

2.  Ocular melanocytoma.

Authors:  C I Thomas; E W Purnell
Journal:  Am J Ophthalmol       Date:  1969-01       Impact factor: 5.258

3.  Efficacy of (123)N-isopropyl-p-[(123)I]-iodoamphetamine single photon emission computed tomography for the diagnosis of uveal malignant melanoma.

Authors:  H Goto; M Usui; I Ishii
Journal:  Am J Ophthalmol       Date:  2001-12       Impact factor: 5.258

Review 4.  Iris melanocytoma: clinical features and natural course in 47 cases.

Authors:  Hakan Demirci; Arman Mashayekhi; Carol L Shields; Ralph C Eagle; Jerry A Shields
Journal:  Am J Ophthalmol       Date:  2005-03       Impact factor: 5.258

5.  Malignant transformation of an iris melanocytoma. A case report.

Authors:  A P Cialdini; J A Sahel; A E Jalkh; J J Weiter; K Zakka; D M Albert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

  5 in total
  2 in total

Review 1.  Don't it make my blue eyes brown: heterochromia and other abnormalities of the iris.

Authors:  I G Rennie
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

2.  Proton beam therapy for presumed and confirmed iris melanomas: a review of 36 cases.

Authors:  Ahmed Rahmi; Hamid Mammar; Juliette Thariat; Gaelle Angellier; Joel Herault; Pierre Chauvel; Laurent Kodjikian; Philippe Denis; Jean Daniel Grange
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-20       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.